| 產品詳情 |
| Edit |   |
|---|
| Product Name | JZP 361 |
|---|
| Description | Potent and selective reversible MAGL inhibitor (IC50 = 46 nM). Exhibits 35-fold and 150-fold higher selectivity over human FAAH and ABHD6, respectively (IC50 values are 1.79 and 7.24 μM, respectively). Displays affinity for H1 receptors (pA2 = 6.81). Exhibits no activity at cannabinoid receptors at 10 μM. Purity 99%. MW (observed): 405.88 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl](1H-1,2,4-triazol-1-yl)methanone |
|---|
| Gene, Accession, CAS # | CAS: 1680193-80-9 |
|---|
| Catalog # | 5851/10 |
|---|
| Price | |
|---|
| Order / More Info | JZP 361 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|